Association between cigarette smoking and FHIT gene alterations in lung cancer

Cancer Research

Volumn 57, Issue 11, 1997, Pages 2121-2123

  Sozzi, Gabriella ^a   Sard, Laura ^a   De Gregorio, Laura ^a   Marchetti, Antonio ^b   Musso, Katia ^a   Buttitta, Fiamma ^b   Tornielli, Silvana ^a   Pellegrini, Silvia ^b   Veronese, Maria Luisa ^d   Manenti, Giacomo ^a   Incarbone, Matteo ^a   Chella, Antonio ^b   Angeletti, Carlo A ^b   Pastorino, Ugo ^c   Huebner, Kay ^d   Bevilaqua, Generoso ^b   Pilotti, Silvana ^a   Croce, Carlo M ^d   Pierotti, Marco A ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c ROYAL BROMPTON HOSPITAL   (United Kingdom)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME 10; CIGARETTE SMOKING; DISEASE ASSOCIATION; GENE FREQUENCY; GENE LOCUS; GENE MUTATION; GENETIC ANALYSIS; GENETIC DAMAGE; GENETIC LINKAGE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LUNG CANCER; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

ACID ANHYDRIDE HYDROLASES; CHROMOSOME DELETION; CHROMOSOME FRAGILITY; CHROMOSOMES, HUMAN, PAIR 10; HETEROZYGOTE; HUMANS; LUNG NEOPLASMS; MICROSATELLITE REPEATS; MIDDLE AGED; NEOPLASM PROTEINS; PROTEINS; SMOKING;

EID: 0030974681     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. IARC. Tobacco Smoking. Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. IARC Sci. Publ., 38: 35-394, 1986.
2. Shopland, D. R., Eyre, H. J., and Pechacek, T. F. Smoking-attributable cancer mortality in 1991: is lung cancer now the leading cause of death among smokers in the United States? J. Natl. Cancer Inst. (Bethesda), 83: 1142-1148, 1991.
3. Ohta, M., Inoue, H., Cotticelli, M. G., Kastury, K., Baffa, R., Palazzo, J., Siprashvili, Z., Mori, M., McCue, P., Druck, T., Croce, C. M., and Huebner, K. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancer. Cell, 84: 587-597, 1996.
4. 3-triphosphate hydrolase. Biochemistry, 35: 11529-11535, 1996.
5. Sozzi, G., Veronese, M. L., Negrini, M., Baffa, R., Cotticelli, M. G., Inoue, H., Tornielli, S., Pilotti, S., De Gregorio, L., Pastorino, U., Pierotti, M. A., Otha, M., Huebner, K., and Croce, C. M. The FHIT gene at 3p14.2 is abnormal in lung cancer. Cell, 85: 17-26, 1996.
6. Virgilio, L., Shuster, M., Gollin, S. M., Veronese, M. L., Ohta, M., Huebner, K., and Croce, C. M. FHIT gene alterations in head and neck squamous cell carcinomas. Proc. Natl. Acad. Sci. USA, 93: 9770-9775, 1996.
7. Mao, L., Fan, Y-H., Lotan, R., and Hong, W. K. Frequent abnormalities of FHIT, a candidate tumor suppressor gene, in head and neck cancer cell lines. Cancer Res., 56: 5128-5131, 1996.
8. WHO. Histological Typing of Lung Tumors. Geneva: WHO, 1981.
9. Sambrook, J., Fritsch, E. F., and Maniatis, T. (eds.). Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
10. Zimonjic, D. B., Druck, T., Ohta, M., Kastury, K., Croce, C. M., Popescu, N. C., and Huebner, K. Positions of chromosome 3p14.2 fragile sites (FRA3B) within the FHIT gene. Cancer Res., 57: 1166-1170, 1997.
11. Suzuki, H., Takahashi, T., Kuroishi, T., Suyama, M., Ariyoshi, Y., and Ueda, R. p53 mutations in non-small cell lung cancer in Japan: association between mutations and smoking. Cancer Res., 52: 734-736, 1992.
12. Takahashi, T., Suzuki, H., Hida, T., Sekido, Y., Ariyoshi, Y., and Ueda, R. The p53 gene is very frequently mutated in small-cell lung cancer with a distinct nucleotide substitution pattern. Oncogene, 6: 1775-1778, 1991.
13. Takeshima, Y., Seyama, T., Bennett, W. P., Akiyama, M., Tokuoka, S., Inai, K., Mabuchi, K., Land, C. E., and Harris, C. C. p53 mutations in lung cancers from non-smoking atomic-bomb survivors (Published erratum in Lancet, 343: 1302, 1994). Lancet, 342: 1520-1521, 1993.
14. Hollstein, M., Sidransky, H., Vogelstein, B., and Harris, C. C. p53 mutations in human cancers. Science (Washington DC), 253: 49-53, 1991.
15. Hecht, S. S., Carmella, S. G., Murphy, S. E., Foiles, P. G., and Chung, F. L. Carcinogen biomarkers related to smoking and upper aerodigestive tract cancer. J. Cell. Biochem. Suppl. 17F: 27-35, 1993.
16. Yunis, J. J., Soreng, A. L., and Bowe, A. E. Fragile sites are targets of diverse mutagens and carcinogens. Oncogene. 1: 59-69, 1987.
17. Denissenko, M. F., Pao, A., Tang, M., and Pfeifer, G. P. Preferential formation of benzo[α]pyrene adducts at lung cancer mutational hotspots in P53. Science (Washington DC), 274: 430-432, 1996.
18. Hung, J., Kishimoto, Y., Sugio, K., Virmani, A., McIntire, D., Minna, J. D., and Gazdar, A. F. Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. J. Am. Med. Assoc., 273: 1928, 1995.
19. Sundaresan, V., Ganly, P., Haselton, P., Rudd, R., Sinha, G., Bleehen, N. M., and Rabbits, P. p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus. Oncogene, 7: 1989-1997, 1992.